ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 1 filers reported holding ITEOS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,996 | +121.9% | 2,648 | +168.3% | 0.00% | – |
| Q2 2023 | $13,068 | +108800.0% | 987 | +9.9% | 0.00% | – |
| Q1 2023 | $12 | +71.4% | 898 | +133.2% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 385 | -96.3% | 0.00% | -100.0% |
| Q3 2022 | $199,000 | +74.6% | 10,446 | +89.0% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -39.7% | 5,527 | -5.6% | 0.00% | +50.0% |
| Q1 2022 | $189,000 | +87.1% | 5,855 | +169.7% | 0.00% | 0.0% |
| Q4 2021 | $101,000 | +573.3% | 2,171 | +285.6% | 0.00% | – |
| Q3 2021 | $15,000 | -51.6% | 563 | -54.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -24.4% | 1,224 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | +64.0% | 1,203 | +61.5% | 0.00% | 0.0% |
| Q4 2020 | $25,000 | -49.0% | 745 | -62.4% | 0.00% | 0.0% |
| Q3 2020 | $49,000 | – | 1,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |